Thomas Stephen Basil - Insider Non-Derivative Transactions at Eliem Therapeutics, Inc. (ELYM) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 27, 2024, Thomas Stephen Basil's relationship to Eliem Therapeutics, Inc. (ELYM) is Director, and currently has 103,907 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ELYM insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Thomas Stephen Basil - Insider Non-Derivative Transactions of ELYM Common Stock

Thomas Stephen Basil - Insider Non-Derivative Transactions at ELYM

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 28, 2024	Acquisition -- (Common Stock)	103907	0	103907